Krsnaa Diagnostics has filed a draft crimson herring prospectus with the market regulator Sebi to boost funds by an preliminary public providing (IPO). The Pune-based diagnostics chain’s IPO will encompass a contemporary problem of shares value Rs 400 crore and a proposal on the market (OFS) of as much as 94,16,377 shares by the present shareholders, together with Phi Capital, Kitara, Somerset Indus Healthcare Fund I and Lotus Management Solutions. The shares might be listed on the BSE and NSE.
A complete of 75 per cent of the problem has been reserved for certified institutional patrons (QIB), 15 per cent for non-institutional buyers and 10 per cent for retail buyers.
The firm will use the proceeds from the share sale to arrange diagnostics centres at Punjab, Karnataka, Himachal Pradesh and Maharashtra, repay present loans and for normal company functions.
Krsnaa Diagnostics gives a spread of diagnostic providers, together with imaging (together with radiology), pathology and tele-radiology.
JM Financial, DAM Capital Advisor, Enquires Capital and IIFL Securities are service provider bankers to the IPO.